Our group actively participated to the EORTC–PAMM winter meeting 2020. The meeting was organised by the PAMM Scientific Committee and by the local organizers Prof. Stig Linder and Dr. Padraig D’Arcy in the wonderful auditorium of Karolinska Institute. continue reading →
Roma/Milano
The results of our study have been published in the “European Journal of Cancer” (2019 Aug 19;119:107-111), official journal Of the European Organization for Research and Treatment of Cancer (EORTC). continue reading →
Pisa,
The review written by the Btissame El Hassouni (PhD student, Dept. Medical Oncology, VUmc) on the role glycolytic metabolism pathway (and new anticancer agents targeting this pathway has been published in Seminars of Cancers Biology continue reading →
Shiraz,
Our collaborative paper with Prof. Firuzi (University of Shiraz, Iran) and the PhD student Pei Pei Che (Department of Radiobiology, VUmc) on the role of c-MET Inhibitors in Overcoming Drug Resistance in Spheroids of Human PDAC and Stellate Cells has been published at continue reading →
Amburgo,
Intervista del Dr. Filippo Cortesi (Universitaetsklinikum Hamburg-Eppendorf, Amburgo) che ha vinto una pretigiosa borsa iCARE AIRC e ricorda la nostra collabotrazione durante la sua internship come studente. continue reading →
Carrara,
Dr. Giovannetti participated to the congress organized by Dr. Mambrini on the role of a multidisciplinary approach for the treatment of pancreatic cancer. continue reading →
Verona,
For the first time the EORTC-PAMM group organized an educational course on “(pre)clinical pharmacology of anticancer drugs”
continue reading →
Roma,
“Onorata di aver partecipato all’incontro con il presidente Mattarella al Quirinale, durante la Giornata della Ricerca sul Cancro. “I giovani che fanno il mestiere del ricercatore sono l’investimento più proficuo e produttivo per il futuro dell’Italia, ed il compito della politica, che ci ha accolto in questa sede, è cercare di agevolarci e di costruire possibilità perché possiamo lavorare al meglio. continue reading →
Ottaviani S, Stebbing J, Frampton AE, Krell J, de Giorgio A, Trabulo SM, Nguyen VTM, Magnani L, Giovannetti E, Funel N, Gress TM, Jiao LR, Lombardo Y, Heeschen C, Castellano L. TGF-ß induces miR-100 and miR-125b but blocks let-7a through LIN28B controlling EMT and stemness. Nat Comm 2018;9(1):1845
www.ncbi.nlm.nih.gov/pubmed/29748571
Presse releases have been published in UK and the The Netherlands, as follows:
The pharmacology group has identified key microRNAs controlling pancreatic cancer progression – a study published in Nature Communications continue reading →
Washington,
A press release on the MARF website described our article published on Annals of Oncology:
www.ncbi.nlm.nih.gov/pubmed/28945836
“These findings identify for the first time PCFT (a protein) as a novel mesothelioma prognostic biomarker, prompting prospective trials for its validation.” continue reading →
Pesaro,
Dr. Giovannetti participated with a lecture on “Optimizing immunotherapy: Rationale for a combination therapy approach” to the 3th INTERNATIONAL COURSE OF ENDOVASCULAR ONCOLOGY: A GLANCE BEYOND YOUR PRACTICE continue reading →
Pisa/Amsterdam/Baltimore,
“A synthetic lethal bullet” by Christian Rolfo & Elisa Giovannetti has been published on Nature Nanotechnology continue reading →
Brussels,
The European Organization for Research and Treatment of Cancer (EORTC) has selected 34 young oncologists/researchers for the EORTC ECI leadership programme, focused on EORTC-specific themes, as well as specific leadership attributes, inspiring meeting with “thematic guests” and challenging tasks for shaping the future of EORTC. continue reading →
Amsterdam,
Important results of collaborative studies with the group of Prof. Wurdinger (Department of Neurosurgery, VU University Medical Center (VUmc), Cancer Center Amsterdam (CCA); Department of Neurology, Massachusetts General Hospital and Neuroscience Program, Harvard Medical School, Charlestown, MA, USA) have been published in Cancer Cell. continue reading →
Antwerp,
Our “Amsterdam/Antwerp-shared” student Nele Van Der Steen has successfully discussed her PhD Thesis on “The labyrinth of cMET and EGFR signaling in non-small cell lung cancer” at the University of Antwerp. continue reading →
Bethesda,
We were extremely pleased to participate to this important meeting where mesothelioma patients, scientists, caregivers, family members, bereaved, and medical professionals came together for conference sessions, socialization, award presentations, and advocacy. continue reading →
Roma,
Our collaborator Dr. Chiara Caparello has been awarded for the best presentation at the National Congress of the Italian Association for the Study of the Pancreas (AISP). The results of Dr. Caparello studies have been published in the following review and scientific paper: continue reading →
Il 28 aprile si è conclusa la prima fase di un progetto pilota che ha visto come protagonisti AIRC, il Liceo delle scienze applicate “Enrico Fermi” di Lucca ed il laboratorio “Cancer Pharmacology Lab, Airc Start-up Unit” dell’Università di Pisa. L’iniziativa è partita a novembre 2015, in occasione del mese della continue reading →
Fra i sedici progetti recentemente selezionati dalla Regione Toscana per il Bando Fas Salute (“per sostenere la ricerca in materia di qualità della vita, salute, in campo biomedicale e industriale”), c’è un progetto pisano di diagnostica molecolare continue reading →
Our recent article has been described by Dr. Robert Lowery in an article entitled Lung Cancer Cells Use NF-κB Pathway to Subvert Third Generation EGFR Kinase Inhibitors, as follows: “One of these, gefitinib, was the second kinase inhibitor to be approved by the FDA, in 2003, for the treatment of non-small-cell lung cancer (NSCLC); a second EGFR inhibitor, erlotinib, was approved the continue reading →
41st EORTC –PAMM winter meeting: February 13th-15th, 2020 in Stockholm
febbraio 15, 2020
Breastfeeding during R-CHOP chemotherapy: please abstain!
settembre 11, 2019
